The European Medicines Agency is dealing with manufacturer constraints and demand regarding the product Creon, with SSP being in place since May 2024, leading to calls for a government taskforce.
1 report, 1 independent
Updated Jun 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The European Medicines Agency is dealing with manufacturer constraints and demand regarding the product Creon, with SSP being in place since May 2024, leading to calls for a government taskforce.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
European Medicines Agency
highest regulatory authority on medicines in the European Union
-
SSP
company in Shinjuku, Japan
-
government
system or group of people governing an organized community, often a state